vs
Side-by-side financial comparison of BLACKLINE, INC. (BL) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
BLACKLINE, INC. is the larger business by last-quarter revenue ($183.2M vs $164.7M, roughly 1.1× PTC THERAPEUTICS, INC.). BLACKLINE, INC. runs the higher net margin — 2.7% vs -82.0%, a 84.6% gap on every dollar of revenue. On growth, BLACKLINE, INC. posted the faster year-over-year revenue change (8.1% vs -22.7%). BLACKLINE, INC. produced more free cash flow last quarter ($26.1M vs $-36.6M). Over the past eight quarters, BLACKLINE, INC.'s revenue compounded faster (7.9% CAGR vs -11.5%).
BlackLine Systems, Inc., is an American enterprise software company that develops cloud-based services designed to automate and manage the entire financial close process as well as consolidation, invoice-to-cash, and intercompany accounting. The Los Angeles–based company has 17 offices worldwide.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
BL vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $183.2M | $164.7M |
| Net Profit | $4.9M | $-135.0M |
| Gross Margin | 75.2% | — |
| Operating Margin | 3.7% | -43.3% |
| Net Margin | 2.7% | -82.0% |
| Revenue YoY | 8.1% | -22.7% |
| Net Profit YoY | -91.3% | -104.8% |
| EPS (diluted) | $0.07 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $183.2M | $164.7M | ||
| Q3 25 | $178.3M | $211.0M | ||
| Q2 25 | $172.0M | $178.9M | ||
| Q1 25 | $166.9M | $1.2B | ||
| Q4 24 | $169.5M | $213.2M | ||
| Q3 24 | $165.9M | $196.8M | ||
| Q2 24 | $160.5M | $186.7M | ||
| Q1 24 | $157.5M | $210.1M |
| Q4 25 | $4.9M | $-135.0M | ||
| Q3 25 | $5.3M | $15.9M | ||
| Q2 25 | $8.3M | $-64.8M | ||
| Q1 25 | $6.1M | $866.6M | ||
| Q4 24 | $56.4M | $-65.9M | ||
| Q3 24 | $17.2M | $-106.7M | ||
| Q2 24 | $76.7M | $-99.2M | ||
| Q1 24 | $10.8M | $-91.6M |
| Q4 25 | 75.2% | — | ||
| Q3 25 | 75.1% | — | ||
| Q2 25 | 75.2% | — | ||
| Q1 25 | 75.5% | — | ||
| Q4 24 | 75.6% | — | ||
| Q3 24 | 75.2% | — | ||
| Q2 24 | 74.9% | — | ||
| Q1 24 | 75.2% | — |
| Q4 25 | 3.7% | -43.3% | ||
| Q3 25 | 4.3% | 1.4% | ||
| Q2 25 | 4.4% | -19.5% | ||
| Q1 25 | 2.1% | 82.5% | ||
| Q4 24 | 3.7% | -76.2% | ||
| Q3 24 | 5.0% | -27.7% | ||
| Q2 24 | 1.4% | -21.5% | ||
| Q1 24 | 1.1% | -21.6% |
| Q4 25 | 2.7% | -82.0% | ||
| Q3 25 | 3.0% | 7.5% | ||
| Q2 25 | 4.8% | -36.3% | ||
| Q1 25 | 3.6% | 73.7% | ||
| Q4 24 | 33.3% | -30.9% | ||
| Q3 24 | 10.4% | -54.2% | ||
| Q2 24 | 47.8% | -53.1% | ||
| Q1 24 | 6.9% | -43.6% |
| Q4 25 | $0.07 | $-1.63 | ||
| Q3 25 | $0.09 | $0.20 | ||
| Q2 25 | $0.13 | $-0.83 | ||
| Q1 25 | $0.10 | $10.04 | ||
| Q4 24 | $0.79 | $-0.85 | ||
| Q3 24 | $0.27 | $-1.39 | ||
| Q2 24 | $0.22 | $-1.29 | ||
| Q1 24 | $0.17 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $390.0M | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $332.3M | $-205.3M |
| Total Assets | $1.8B | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $390.0M | $1.9B | ||
| Q3 25 | $419.9M | $1.7B | ||
| Q2 25 | $459.1M | $2.0B | ||
| Q1 25 | $479.5M | $2.0B | ||
| Q4 24 | $885.9M | $1.1B | ||
| Q3 24 | $725.3M | $1.0B | ||
| Q2 24 | $616.6M | $1.1B | ||
| Q1 24 | $331.4M | $884.8M |
| Q4 25 | $332.3M | $-205.3M | ||
| Q3 25 | $328.3M | $-155.8M | ||
| Q2 25 | $414.0M | $-206.5M | ||
| Q1 25 | $417.9M | $-185.8M | ||
| Q4 24 | $446.7M | $-1.1B | ||
| Q3 24 | $367.9M | $-1.1B | ||
| Q2 24 | $325.8M | $-980.2M | ||
| Q1 24 | $279.8M | $-893.9M |
| Q4 25 | $1.8B | $2.9B | ||
| Q3 25 | $1.7B | $2.6B | ||
| Q2 25 | $1.8B | $2.6B | ||
| Q1 25 | $1.8B | $2.7B | ||
| Q4 24 | $1.8B | $1.7B | ||
| Q3 24 | $1.7B | $1.8B | ||
| Q2 24 | $1.9B | $1.9B | ||
| Q1 24 | $2.1B | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.7M | $-34.3M |
| Free Cash FlowOCF − Capex | $26.1M | $-36.6M |
| FCF MarginFCF / Revenue | 14.2% | -22.3% |
| Capex IntensityCapex / Revenue | 0.3% | 1.4% |
| Cash ConversionOCF / Net Profit | 5.46× | — |
| TTM Free Cash FlowTrailing 4 quarters | $161.5M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.7M | $-34.3M | ||
| Q3 25 | $63.8M | $-66.3M | ||
| Q2 25 | $32.3M | $-58.3M | ||
| Q1 25 | $46.7M | $870.1M | ||
| Q4 24 | $43.8M | $-30.0M | ||
| Q3 24 | $55.9M | $-77.0M | ||
| Q2 24 | $40.7M | $-71.5M | ||
| Q1 24 | $50.4M | $70.8M |
| Q4 25 | $26.1M | $-36.6M | ||
| Q3 25 | $63.3M | $-69.7M | ||
| Q2 25 | $31.4M | $-59.6M | ||
| Q1 25 | $40.8M | $868.4M | ||
| Q4 24 | $43.0M | $-33.8M | ||
| Q3 24 | $55.5M | $-77.5M | ||
| Q2 24 | $40.0M | $-78.8M | ||
| Q1 24 | $50.1M | $61.2M |
| Q4 25 | 14.2% | -22.3% | ||
| Q3 25 | 35.5% | -33.1% | ||
| Q2 25 | 18.2% | -33.3% | ||
| Q1 25 | 24.4% | 73.8% | ||
| Q4 24 | 25.4% | -15.8% | ||
| Q3 24 | 33.5% | -39.4% | ||
| Q2 24 | 24.9% | -42.2% | ||
| Q1 24 | 31.8% | 29.1% |
| Q4 25 | 0.3% | 1.4% | ||
| Q3 25 | 0.3% | 1.6% | ||
| Q2 25 | 0.6% | 0.7% | ||
| Q1 25 | 3.6% | 0.1% | ||
| Q4 24 | 0.4% | 1.8% | ||
| Q3 24 | 0.2% | 0.3% | ||
| Q2 24 | 0.4% | 4.0% | ||
| Q1 24 | 0.2% | 4.6% |
| Q4 25 | 5.46× | — | ||
| Q3 25 | 12.07× | -4.17× | ||
| Q2 25 | 3.90× | — | ||
| Q1 25 | 7.72× | 1.00× | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | 3.24× | — | ||
| Q2 24 | 0.53× | — | ||
| Q1 24 | 4.66× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BL
| Subscription And Circulation | $173.2M | 95% |
| Technology Service | $10.0M | 5% |
PTCT
Segment breakdown not available.
